Sectors

LFMD
LifeMD, Inc.
3.12
10 x 2.78
4 x 4.99
bid
ask
-
0.02
0.80%
02:09 PM
timesize
Ytd-8.65%
1y-49.68%
3.08
day range
3.28
2.56
52 week range
7.32
Open3.20Prev Close3.14Low3.08High3.28Mkt Cap150.63M
Vol452.04KAvg Vol934.55KEPS-0.53P/EN/AForward P/E-124.75
Beta2.02Short Ratio7.78Inst. Own40.48%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-0950-d Avg3.94200-d Avg3.891yr Est12.00

LFMD News

benzinga.com
HC Wainwright & Co. Maintains Buy on LifeMD, Lowers Price Target to $9

HC Wainwright & Co. analyst Yi Chen maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the

benzinga.com
B. Riley Securities Maintains Buy on LifeMD, Lowers Price Target to $8

B. Riley Securities analyst William Woods maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers th

LifeMD, Inc. (LFMD) Q2 2026 Earnings Call Transcript
seekingalpha.com
LifeMD, Inc. (LFMD) Q2 2026 Earnings Call Transcript

LifeMD, Inc. (LFMD) Q2 2026 Earnings Call Transcript

LifeMD Q2 Earnings Call Highlights
marketbeat.com
LifeMD Q2 Earnings Call Highlights

LifeMD NASDAQ: LFMD reported second-quarter revenue of $47.3 million, within its prior guidance rang

LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates
zacks.com
LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates

LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Est

UPDATE - LifeMD Reports Second Quarter 2026 Results
globenewswire.com
UPDATE - LifeMD Reports Second Quarter 2026 Results

UPDATE this press release has been updated to remove a duplicate table. Second quarter 2026 revenue

benzinga.com
LifeMD Lowers FY2026 Sales Guidance from $220.000M-$230.000M to $205.500M-$212.500M vs $222.046M Est

LifeMD (NASDAQ:LFMD) lowers FY2026 sales outlook from $220.000 million-$230.000 million to $205.500

benzinga.com
LifeMD Q2 EPS $(0.16) Misses $(0.15) Estimate, Sales $47.300M Miss $49.152M Estimate

LifeMD (NASDAQ:LFMD) reported quarterly losses of $(0.16) per share which missed the analyst consens

Critical Survey: Ryman Healthcare (OTCMKTS:RYHTY) vs. LifeMD (NASDAQ:LFMD)
defenseworld.net
Critical Survey: Ryman Healthcare (OTCMKTS:RYHTY) vs. LifeMD (NASDAQ:LFMD)

LifeMD (NASDAQ: LFMD - Get Free Report) and Ryman Healthcare (OTCMKTS:RYHTY - Get Free Report) are b

LifeMD to Report Second Quarter 2026 Financial Results on August 5
globenewswire.com
LifeMD to Report Second Quarter 2026 Financial Results on August 5

NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtu

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
globenewswire.com
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading direct-to-patient

benzinga.com
LifeMD To Launch Program For XYOSTED Injection

LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and specialty care today ann

LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection
globenewswire.com
LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (

Landmark agreement between a leading virtual care company and a pharmaceutical manufacturer establis

LifeMD Appoints Umesh Sripad as Chief Technology Officer
globenewswire.com
LifeMD Appoints Umesh Sripad as Chief Technology Officer

NEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading direct-to-patient

LifeMD to Participate in Upcoming Investor Conferences
globenewswire.com
LifeMD to Participate in Upcoming Investor Conferences

NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading platform for virtu

LifeMD, Inc. (LFMD) Q1 2026 Earnings Call Transcript
seekingalpha.com
LifeMD, Inc. (LFMD) Q1 2026 Earnings Call Transcript

LifeMD, Inc. (LFMD) Q1 2026 Earnings Call Transcript

LifeMD, Inc. (LFMD) Reports Q1 Loss, Tops Revenue Estimates
zacks.com
LifeMD, Inc. (LFMD) Reports Q1 Loss, Tops Revenue Estimates

LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Esti

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

Earnings Scheduled For May 6, 2026
benzinga.com
Earnings Scheduled For May 6, 2026

benzinga.com
LifeMD Affirms FY2026 Sales Guidance of $220.000M-$230.000M vs $223.588M Est

LifeMD (NASDAQ:LFMD) affirms FY2026 sales outlook from $220.000 million-$230.000 million to $220.000

benzinga.com
LifeMD Q1 EPS $(0.20) Beats $(0.23) Estimate, Sales $50.163M Beat $48.842M Estimate

LifeMD (NASDAQ:LFMD) reported quarterly losses of $(0.20) per share which beat the analyst consensus

LifeMD Reports First Quarter 2026 Results
globenewswire.com
LifeMD Reports First Quarter 2026 Results

First quarter 2026 revenue of $50.2 million and adjusted EBITDA loss of $4.5 million, above and in l

LifeMD to Report First Quarter 2026 Financial Results on May 6
globenewswire.com
LifeMD to Report First Quarter 2026 Financial Results on May 6

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virt

Amazon GLP-1 Program Pressures Hims & Hers Stock
benzinga.com
Amazon GLP-1 Program Pressures Hims & Hers Stock

Hims & Hers stock falls as Amazon launches a weight loss program with integrated care, pricing o

LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock?
zacks.com
LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock?

LifeMD (LFMD) was a big mover last session on higher-than-average trading volume. The latest trend i

benzinga.com
LifeMD Now Offers Eli Lilly's Foundayo To Eligible Patients Through Its Weight Management Program

LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced tha

LifeMD® Now Offering Eli Lilly and Company's Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management
globenewswire.com
LifeMD® Now Offering Eli Lilly and Company's Foundayo™ (orforglipron), a New GLP-1 Pill for Weight M

LifeMD expands its weight management program with the addition of Foundayo, offering eligible patien

Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan
benzinga.com
Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan

Novo Nordisk launches the first Wegovy subscription program. Save on injections and pills through Ro

benzinga.com
LifeMD Launches Novo Nordisk Wegovy Subscription Program, Offering First Branded GLP-1 Telehealth Ac

LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced the

LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program
globenewswire.com
LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program

Delivering up to $1,200 in annual patient savings on branded GLP-1 therapy, expanding LifeMD's colla

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
globenewswire.com
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virt

benzinga.com
LifeMD Appoints Atul Kavthekar CFO, Effective March 16, Succeeding Marc Benathen

https://www.sec.gov/Archives/edgar/data/948320/0001493152-26-011228-index.html

benzinga.com
LifeMD Appoints Atul Kavthekar CFO, Effective Immediately, Succeeding Marc Benathen

LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced the

This Upstart Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
benzinga.com
This Upstart Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

Wall Street analysts upgraded PennyMac, LifeMD, Upstart, Circle Internet, and Rocket Companies. See

benzinga.com
Mizuho Upgrades LifeMD to Outperform, Raises Price Target to $8

Mizuho analyst Steven Valiquette upgrades LifeMD (NASDAQ:LFMD) from Neutral to Outperform and rai

benzinga.com
Freedom Capital Markets Maintains Buy on LifeMD, Raises Price Target to $10

Freedom Capital Markets analyst Ilya Zubkov maintains LifeMD (NASDAQ:LFMD) with a Buy and raises

Uniqure To Rally Around 92%? Here Are 10 Top Analyst Forecasts For Wednesday
benzinga.com
Uniqure To Rally Around 92%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on top names. See all changes on analyst ratings page

benzinga.com
HC Wainwright & Co. Maintains Buy on LifeMD, Raises Price Target to $10

HC Wainwright & Co. analyst Yi Chen maintains LifeMD (NASDAQ:LFMD) with a Buy and raises the

LifeMD: Q4 Earnings Insights
benzinga.com
LifeMD: Q4 Earnings Insights

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

benzinga.com
LifeMD Q4 EPS $(0.04) Beats $(0.06) Estimate, Sales $46.868M Beat $46.848M Estimate

LifeMD (NASDAQ:LFMD) reported quarterly losses of $(0.04) per share which beat the analyst consensus

Earnings Scheduled For March 9, 2026
benzinga.com
Earnings Scheduled For March 9, 2026

Earnings Outlook For LifeMD
benzinga.com
Earnings Outlook For LifeMD

Novo Nordisk's Wegovy Weight Loss Pill Hits US Pharmacies With Lower Starting Cost
benzinga.com
Novo Nordisk's Wegovy Weight Loss Pill Hits US Pharmacies With Lower Starting Cost

Novo Nordisk launches Wegovy weight loss pill in the US, showing up to 17% weight loss, with prices

Benzinga Bulls And Bears: Nvidia, Webull, Netflix — And Tech Stocks Face Worst Sell-Off Since April
benzinga.com
Benzinga Bulls And Bears: Nvidia, Webull, Netflix — And Tech Stocks Face Worst Sell-Off Since April

Benzinga examined the prospects for many investors' favorite stocks over the last week — here&#3

Eli Lilly To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday
benzinga.com
Eli Lilly To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday

benzinga.com
HC Wainwright & Co. Maintains Buy on LifeMD, Lowers Price Target to $9

HC Wainwright & Co. analyst Yi Chen maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the

benzinga.com
Keybanc Maintains Overweight on LifeMD, Lowers Price Target to $8

Keybanc analyst Steve Dechert maintains LifeMD (NASDAQ:LFMD) with a Overweight and lowers the pr

benzinga.com
Mizuho Maintains Neutral on LifeMD, Lowers Price Target to $6

Mizuho analyst Steven Valiquette maintains LifeMD (NASDAQ:LFMD) with a Neutral and lowers the pri

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session